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ABSTRACT: The inclusion of magnetic nanoparticles (MNP) in a
hydrogel matrix to produce magnetic hydrogels has broadened the scope
of these materials in biomedical research. Embedded MNP offer the
possibility to modulate the physical properties of the hydrogel remotely
and on demand by applying an external magnetic field. Moreover, they
enable permanent changes in the mechanical properties of the hydrogel,
as well as alterations in the micro- and macroporosity of its three-
dimensional (3D) structure, with the associated potential to induce
anisotropy. In this work, the behavior of biocompatible and
biodegradable hydrogels made with Fmoc-diphenylalanine (Fmoc-FF)
(Fmoc = fluorenylmethoxycarbonyl) and Fmoc−arginine−glycine−
aspartic acid (Fmoc-RGD) short peptides to which MNP were
incorporated was studied in detail with physicochemical, mechanical, and biological methods. The resulting hybrid hydrogels
showed enhance mechanical properties and withstood injection without phase disruption. In mice, the hydrogels showed faster and
improved self-healing properties compared to their nonmagnetic counterparts. Thanks to these superior physical properties and
stability during culture, they can be used as 3D scaffolds for cell growth. Additionally, magnetic short-peptide hydrogels showed
good biocompatibility and the absence of toxicity, which together with their enhanced mechanical stability and excellent injectability
make them ideal biomaterials for in vivo biomedical applications with minimally invasive surgery. This study presents a new
approach to improving the physical and mechanical properties of supramolecular hydrogels by incorporating MNP, which confer
structural reinforcement and stability, remote actuation by magnetic fields, and better injectability. Our approach is a potential
catalyst for expanding the biomedical applications of supramolecular short-peptide hydrogels.
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■ INTRODUCTION
Injectable hydrogels are useful materials with advanced
biomedical applications in the fields of tissue engineering
and drug delivery (including macromolecules and cells) and in
surgery as void-fillers, bioadhesives, or antiadhesives.1−3 These
hydrogels show potential for use in therapy with minimally
invasive procedures requiring only a needle and therefore with
reduced surgical time, pain, and complications. For clinical
purposes, these materials must meet high standards involving
specific technical requirements to successfully perform their
designated functions.4−6 Moreover, they must be completely
biocompatible and biodegradable because they are intended
for use inside the human body. Biodegradability inside the
body is a key issue, because drug delivery and cell adhesion or
regeneration are controlled by and can be affected by the rate
of hydrogel degradation; accordingly, the physiological and
therapeutic effects are also modulated by this process.7 The
physical properties of these materials must be well controlled,
remain within specific parameters to ensure that the materials
are fluid enough to be injected, and be rigid or compact
enough to withstand and/or transport cells or drugs. In
addition, they must remain temporarily localized within a
specific tissue in order to exert a therapeutic effect within a
specified period.8 Biocompatibility and physical properties
both depend on the chemical strategy used to develop these
systems.7
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To achieve biocompatibility, hydrogels have been developed
mainly with materials from natural sources such as alginate,
agarose, collagen, gelatin, silk fibroin, hyaluronic acid, chitosan,
cellulose, and starch, alone or in combination with other
compounds.9 Because injectable hydrogels need to be
sufficiently fluid to flow through a syringe needle, the most
common strategy to ensure injectability is to inject a pregel
mixture or a free-flowing solution that jellifies slowly1 or whose
gelation can be triggered under physiological conditions by
enzymes, salts, temperature changes, or other stimuli.8
However, these in situ gelling hydrogels may have some
drawbacks since, being liquid, their contents can leak into the
body; moreover, the gelling process, as well as the final
biomechanical properties, can be affected by in vivo conditions.
Alternatively, certain hydrogels present the interesting property
of flowing under an applied stress (shear-thinning) and easily
recover their original stiffness after removal of the stress (self-
healing) without the intervention of any external stimulus.8
Shear-thinning hydrogels rely on reversible physical cross-links
and include hydrogels made with self-assembling peptides, in
particular, β-hairpin peptides, which were studied in detail by
Pochan and Schneider,10−12 among others.7,8,13 Because the
latter strategy involves the injection of pre-existing hydrogels,
their mechanical and biological properties can be well
characterized and studied. Moreover, the recovery of
mechanical properties may be faster and less affected by the
environment than in gels triggered by external conditions. The
hydrogel matrix can also be used to carry and deliver sensitive
cargos such as human cells. Consequently, these hydrogels
have been considered excellent candidates for cell therapy.10,12
Other groups of self-assembling peptides that are able to
form physical hydrogels are based on amphiphilic dipep-
tides,14,15 in particular, those containing a fluorenylmethylox-
ycarbonyl (Fmoc) or naphthyl (Nap) group.16−19 These
peptides are easily accessible and economically competitive
and have therefore been used in many important biotechno-
logical applications,20−22 including three-dimensional (3D)
scaffolds for cell culture, since they show self-healing under
specific conditions.23−27 Nevertheless, the injectability of these
gels has been less explored. In the particular case of Fmoc-
diphenylalanine (Fmoc-FF), it was shown that this gel
undergoes phase separation during injection.28 In this
connection, a strategy to improve the properties of some gels
consists of developing composite or hybrid hydrogels made
with different organic or organic + inorganic materials.2 This
strategy has also been applied to Fmoc-dipeptide gels with the
aim of improving their mechanical properties.21,29−31 Recently,
Aviv et al. showed that the combination of Fmoc-FF and
hyaluronic acid gives rise to composite hydrogels with
enhanced mechanical properties that, at specified ratios, can
be injected due to the shear-thinning process, making these
gels excellent vehicles for drug delivery applications.28
Analogously, Li et al. developed an injectable hydrogel for
tissue engineering based on the combination of Nap-FF and
silk fibroin.32
In a previous work, we showed that the mechanical
properties of Fmoc-FF hydrogels can be significantly enhanced
by the incorporation of magnetic nanoparticles (MNP) while
the microporosity of the gel remains unaltered. Moreover, the
incorporation of MNP makes it possible to exert control over
the mechanical properties remotely by applying an external
magnetic field.33 It was recently shown that magnetic hydrogels
(hydrogels in which magnetic micro- or nanoparticles have
been incorporated) offer specific advantages when designed for
biomedical applications such as drug delivery and tissue
engineering.34 These advantages reflect the greater degree of
controllability that magnetic hydrogels can offer. Moreover, the
mechanical or physical properties can be controlled
remotelya feature that makes these materials compatible
with in vivo applications. In this connection, magnetic
hydrogels have been used as pulsatile drug delivery vehicles35
and in tissue engineering for magnetomechanical stimulation
of different cell lines,36,37 among other applications.38−41
In the present work, we developed a new type of injectable
hydrogel that combines within a single system the advantages
of injectability through a shear-thinning process with the
capacity for remote modulation of its mechanical properties by
applying an external magnetic field (Figure 1). This system was
Figure 1. Schematic of the properties of short-peptide supramolecular magnetic hydrogels.
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obtained by combining Fmoc-FF, Fmoc-RGD (Fmoc−
arginine−glycine−aspartic acid), and MNP and has the
following unique features: (1) high biocompatibility and
biodegradability ex vivo and in vivo; (2) high mechanical
stiffness (G′ ≥ 20 KPa), making it suitable as a scaffold for cell
growth; (3) resistance to degradation with time (scaffolds for
cell growth remain unaltered after 30 days); (4) injectability
with improved shear-thinning and self-healing properties; and
(5) responsiveness to an external magnetic field. These
hydrogels can thus be localized in a specific site or can be
moved after injection without losing their phase or
composition and can therefore be used to translocate the gel
or gel cargo to a particular site subcutaneously.
These new systems were tested in vitro as 3D scaffolds for
osteoblast growth and as delivery vehicles for injected
fibroblasts. In addition, the injectability, toxicity, and
persistence of these hydrogels were evaluated in vivo by
subcutaneous injection in mice.
■ RESULTS AND DISCUSSION
Physicochemical Characterization of Hydrogels. The
morphologies of fibers in Fmoc-FF peptide hydrogels (here-
after, Fmoc-FF = FF samples) and FF/Fmoc-RGD hydrogels
(hereafter, Fmoc-RGD = RGD samples) (7:3 ratio) were
studied by TEM for systems with and without MNP. Previous
TEM studies of FF peptide and FF/RGD mixture fibers have
shown the presence of long fibers and ribbons in diameters
ranging from 10 to 150 nm and several micrometers in
length.25,42,43 Ulijn et al. have shown that the morphology of
FF/RGD mixture fibers remains similar to those of FF when
the amount of RGD is equal or lower than 30 M%, which is the
case in the present work.25 As seen in Figure 2, TEM images of
FF peptide (Figure 2A) show fibers with a length-to-diameter
ratio similar to previously reported samples and similar to
those shown in Figure 2B corresponding to the FF/RGD
mixture, in agreement with the results reported by Ulijn et al.25
The incorporation of MNP in both cases (Figure 2C,D) did
not appreciably modify fiber morphology when MNP were
included in the fiber structure as we have previously
reported.33
The preservation of fiber morphology in the presence of
MNP was also confirmed by analysis of the peptide’s secondary
structure within the fibers by CD and FTIR. The CD spectra
of FF and FF/RGD showed a broad band near 280 nm
corresponding to transitions of the fluorenyl groups and an
intense negative peak near 220 nm suggesting a β-sheet-like
peptide secondary structure as previously reported25 (Figure
S1). The similarity of the two spectra confirmed that the
arrangement within the peptide mixture gave rise to packaging
similar to that of FF alone, which was consistent with TEM
images. The CD spectra of the hybrid hydrogels with MNP
confirmed that the presence of MNP did not modify the
secondary structure of the peptide fibers (Figure 2E). The
FTIR spectra also showed compatible results: All samples with
(Figure 2F) and without MNP (Figure S1) produced an
intense band in the amide I region at 1627 cm−1 attributable to
formation of β-sheet structures.
Mechanical Evaluation of Hydrogels. We first studied
the gelation kinetics of our hydrogels by monitoring the
evolution of the storage (G′) and loss (G″) moduli as a
function of time, starting from the mixtures of the reagents. As
observed, G′ increased steeply with time from the very
beginning of the test and continued to increase less steeply
after a few minutes (Figure 3A), which may be ascribed to
rapid, deep gel formation. Indeed, as shown from the loss
tangent curves tan(δ) = G″/G′ vs time during gelation (Figure
3B), the mixtures presented gel-like features from the very
beginning of measurements. It should be noted that 0.1 <
tan(δ) < 1 is typical of weak gels, whereas strong gels present
values of tan(δ) < 0.1. Therefore, our samples demonstrated
borderline behavior between weak and strong gels. Regarding
differences between samples, they all showed similar gelation
Figure 2. Representative TEM images and CD and FTIR spectra of the hydrogels: (A) Fmoc-FF, (B) Fmoc-FF/Fmoc-RGD, (C) Fmoc-FF +
MNP, (D) Fmoc-FF/Fmoc-RGD + MNP, (E) CD of Fmoc-FF + MNP and Fmoc-FF/Fmoc-RGD + MNP, and (F) FTIR of Fmoc-FF + MNP
and Fmoc-FF/Fmoc-RGD + MNP.
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kinetics. We also characterized the mechanical properties of
hydrogels under oscillatory shear after complete gelation.
Amplitude sweeps (Figure 3C) disclosed two identifiable
regions: the linear viscoelastic region (LVR) characterized by
G′ and G″ values almost independent of shear strain amplitude
and with G′ > G″ as expected for gel-like materials. At higher
values of shear strain amplitude, G″ increased steadily up to its
maximum value, known as the yield point, while G′ decreased
steadily. These changes marked the onset of the second region
referred to as the nonlinear viscoelastic region (NLVR).
Within the NLVR, the viscoelastic moduli decreased markedly
in relation to destruction of the gel-like network, and
eventually, transition to a liquid-like behavior (G′ < G″)
occurred. The mechanical spectra of samples, i.e., the
frequency sweeps for a constant shear strain amplitude (γ0 =
0.001) within the LVR (Figure 3D), demonstrated almost
frequency-independent trends for G′, typical of densely cross-
linked gels. In contrast, G″ showed a weak tendency to
increase up to a frequency of 4 Hz and decreased thereafter.
Comparison of the viscoelastic moduli for different samples
(Figure 3E) showed that FF samples produced the weakest
response (smallest values of G′ and G″ within the LVR) and
the addition of RGD resulted in a slight enhancement in
strength, whereas the addition of MNP markedly enhanced
strength by inducing an almost 7-fold increase in G′ and G″.
Mechanical strengthening of hydrogels induced by the
inclusion of solid particles in the formulation has been widely
reported for polymer gels and has been found to be a result of
changes in cross-linking or in the microstructure of the 3D
polymer network, simply a direct result of embedment of solid
inclusions, or a combination of all these effects.33,44−46
Application of a magnetic field during gelation (FF + RGD +
MNP + H sample) resulted in a large decrease in G′ and G″
compared to the sample with MNP but gelled in the absence of
a magnetic field (FF + RGD + MNP sample). It should be
noted that the effect of inclusion of MNP in FF hydrogels (not
containing RGD) was studied previously by our group,33 and
we found that the per se inclusion of MNP did not lead to
noticeable changes in the mechanical properties, whereas the
combination of MNP addition with magnetic field application
Figure 3. Mechanical response of the hydrogels. Representative curves for storage modulus (A) and loss tangent (B) as a function of time during
gelation starting from mixtures of pregel reagents. In amplitude sweeps (C) and frequency sweeps (D) for completely gelled hydrogels, the data
represent mean values ± standard errors of at least three independent measurements in different hydrogels for each experimental condition. Mean
values ± standard errors (for three different repeats and three different hydrogels, i.e., nine values per experimental condition) of viscoelastic
moduli within the LVR (E) for completely gelled hydrogels. Representative curves of the evolution of the storage modulus (F) and loss tangent (G)
during a self-healing test after injection of the hydrogels through a syringe.
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during gelation resulted in strengthened anisotropic hydrogels.
Anisotropy in these hydrogels appeared because of MNP
migration and aggregation into column-like structures due to
the attractive forces between MNP induced by the magnetic
field applied during gelation. We demonstrated the anisotropic
microstructure of the resulting magnetic hydrogels with light
microscopy, and their anisotropic mechanical properties were
demonstrated with rheological measurements under shear in
two directions perpendicular to the applied field.33
Finally, we tested whether the hydrogels recovered their gel-
like characteristics after injection through a syringe. For this
purpose, we injected the samples directly onto the measuring
sensor of the rheometer and subsequently monitored the
evolution of the viscoelastic moduli with time. All samples
showed a steady increase of G′ in the post-injection step
(Figure 3F), although only the sample subjected to a magnetic
field during this step attained values of G′ of the same order of
magnitude as before injection, likely due to the combined
effect of magnetic attraction between the particles and recovery
of the supramolecular interactions between peptides. For other
samples not subjected to a magnetic field during the post-
injection step, the storage modulus after 120 min of self-
healing was almost two orders of magnitude smaller than
before injection (compare Figure 3F,C). This incomplete
recovery of strength of the hydrogels after injection was also
evident from the tan(δ) curves (Figure 3G). As observed,
tan(δ) values were appreciably larger than 0.1 and thus typical
of weak gels, especially at the shortest times and for samples
not subjected to a magnetic field in the post-injection step in
contrast to the values of tan(δ) ≈ 0.1 observed in gelation
kinetics (Figure 3B). Although pre-injection values did not
fully recover, the hydrogels tested here clearly showed self-
healing behavior.
Ex Vivo Evaluation of Hydrogels. To analyze the ex vivo
biocompatibility of the hydrogels, we prepared 3D cell cultures
of osteoblasts in different experimental groups during two
different culture periods (Figure 4). It should first be noted
that samples not containing MNP were completely degraded at
38 days of cell culture and could therefore not be further
evaluated at this time. Visualization with HE staining revealed
a large, statistically significant (P < 0.05) increase in the
number of cells between day 12 and day 38 (graphs in Figure
4). At both time points, the addition of RGD and/or MNP
appeared to have a positive effect on cell survival/proliferation.
This positive effect of RGD in cell cultures is not surprising,
since it is known to be a promoter of cell adhesion.25,47
Regarding the role of MNP and in agreement with our results
for peptide hydrogels, several previous studies reported that
when MNP are added to polymeric scaffolds for tissue
engineering applications, they stimulate adhesion, proliferation,
and differentiation of cells in vitro and even bone formation in
vivo.48−50 In the present work, differences between cell
Figure 4. Hematoxylin and eosin staining. Bright pink dots represent cells (some of which are marked with blue arrows). Pale pink areas are the
matrix media not containing magnetic nanoparticles (MNP). Matrix media containing MNP are mostly dark-colored. MNP: hydrogels containing
MNP; MNP + H: hydrogels containing MNP and jellified under a magnetic field; NO MNP: hydrogels not containing MNP. FF Matrix: Fmoc-FF
peptide matrix; FF + RGD Matrix: hybrid matrix based on both Fmoc-FF and Fmoc-RGD peptides. Note that hydrogels not containing MNP were
completely degraded at 38 days of cell culture, thus making it impossible to perform histochemical analysis. Photographs are representative images
of each experimental condition. Data in the graphs represent the mean values ± standard errors of cell count from four different cross sections from
a single scaffold.
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proliferation in different samples correlated well with differ-
ences in mechanical properties: Stronger hydrogels (higher G′)
connected with larger numbers of cells at a given cell culture
period. This result is not unexpected, given that cells are
sensitive to the mechanical properties of the surrounding
medium, with appropriate mechanical properties usually being
considered an essential characteristic for biocompatibility of
biomaterials.51 Therefore, our results appear to indicate that
improved osteoblast proliferation was due, at least partially, to
the enhanced mechanical properties of the hydrogels.
To further analyze cell proliferation in the hydrogels, we
used immunohistochemical staining to investigate the potential
expression of Ki-67 antigen. Note that Ki-67 antigen is a large
nuclear protein (its two main isoforms have theoretical
molecular weights of 345 and 395 kDa) preferentially
expressed during all active phases of the cell cycle but absent
in resting cells. This protein is required to maintain individual
mitotic chromosomes dispersed in the cytoplasm after nuclear
disassembly. Our results demonstrate that at 38 days of cell
culture, 15−20% of cells were in active phases of the cell cycle
for hydrogels containing MNP, regardless of whether a
magnetic field was applied or whether RGD was added
(Figure S2). Hydrogels not containing MNP were completely
degraded at 38 days, precluding immunohistochemical
analysis. Taken together, these results further support the
notion that hydrogels containing MNP are suitable to promote
osteoblastic cell growth.
In separate experiments, we quantified the DNA released
from fibroblasts cultured in FF + RGD after 24 h, 72 h, and 1
week of cell culture. The results (Figure S3) yielded 566.2 ±
178.47 ng/μL in human cells cultured for 24 h in the presence
of these hydrogels, 628.76 ± 192.95 ng/μL at 72 h, and 439.55
± 159.41 ng/μL at 1 week. These findings confirm the
presence of cells within the hydrogels after different cell culture
periods and suggest that they were able to proliferate within
the hydrogels. In this connection, previous work by our group
demonstrated that cells remained viable and were able to
proliferate within hydrogels containing MNP, as determined by
the quantification of DNA and WST-1 activity.38,52 Future
studies with longer culture periods are warranted to
corroborate these preliminary results.
Degradation and Swelling Behavior. As noted in the
previous section, samples not containing MNP were
completely degraded after 38 days of cell culture. To further
investigate hydrogel stability, we observed the changes over
time in the degradation and swelling behavior of acellular
hydrogels. All samples showed signs of degradation, e.g., loss of
integrity (Figure 6 and Figure S4) and decreased mass in
swelling experiments (Figure S5). However, this result was not
incompatible with the high stability of cellular samples as
observed in experiments carried out for ex vivo evaluation,
given that we found in previous work with magnetic fibrin−
agarose hydrogels that the presence of cells stabilized hydrogels
against degradation over a follow-up period of 30 days.53 In the
present study, the combination of cells and MNP appeared to
have a synergistic effect in preventing degradation in magnetic
peptide hydrogels. A noteworthy finding was that no signs of
MNP corrosion were observed, which supports the effective-
ness of coating for this aim in agreement with previous work in
which we reported that coating with polyethylene glycol
(PEG) protected MNP from mildly acidic media.38
In Vivo Biocompatibility of Particles and Hydrogels.
To determine the in vivo biocompatibility of the particles and
hydrogels analyzed here, they were injected subcutaneously in
laboratory mice. It should be noted that magnetic hydrogels
responded to a magnetic field applied after subcutaneous
injection in the mice (Video S1). Mice that received implants
showed no detectable signs of systemic alterations as
determined by hematological testing (Table S1). Specifically,
we found that all parameters for red blood cells, white blood
cells, and platelets were similar in all three groups (controls,
animals grafted with particles and with the hydrogels for 1
week, and animals grafted for 30 days) and none of the
parameters differed significantly compared to the control
animals (P > 0.05). We then used histological methods to
analyze five major organs (spleen, liver, kidney, heart, and
lung), and found that the implant was not associated with
significant structural alterations in any organ after 1 week and 1
month of in vivo follow-up (Figure 5). The histological
structure of the spleen was compatible with a normal organ in
all cases, with abundant lymphoid cells organized in white pulp
and red pulp as previously described for the normal spleen.
Analysis of the liver revealed the presence of numerous
hepatocytes forming normal lobules around a central vein. In
the kidney, we found abundant renal corpuscles and collecting
Figure 5. Histological analysis with hematoxylin and eosin staining of
five major organs in mice (spleen, liver, kidney, heart, and lung) 1
week and 1 month after in vivo grafting. Each animal in the 1-week
and 1-month groups was grafted with MNP diluted in saline, hydrogel
consisting of FF + RGD, or hydrogel consisting of FF + RGD + MNP
at different sites in the dorsal area, whereas controls were native
nongrafted mice. Scale bar, 200 μm. Photographs are representative
images of each experimental condition.
Figure 6. Degradation studies. Representative images of acellular
hydrogels at selected periods after preparation (time, T, is indicated in
days, d). See Figure S4 for additional images obtained at different
periods after preparation.
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tubes with no detectable alterations. Histological analysis of
the heart showed a normal structure consisting of inter-
connected cardiomyocytes, and the structure of the lung was
also compatible with a normal organ, with abundant alveoli
lined by flattened pneumocytes in all animals. None of the
organs showed any microscopic signs of MNP migration or
any detectable alterations. These results suggest that the
particles and the different hydrogels analyzed here were safe for
the host animal and were not associated with any systemic side
effects.
In addition, we analyzed the implant site to search for local
effects of each hydrogel. As found in hematological and
histological studies of the organs, the results confirmed the
biocompatibility of the particles and hydrogels and that none
of the grafted animals showed any histological signs of
inflammation, infection, necrosis, hemorrhage, or tumori-
genesis 1 week and 1 month after in vivo grafting (Figure
7). Note also that no signs of MNP corrosion were observed in
any of the implants.
Findings at the site injected with saline were compatible
with normal subcutaneous tissue consisting of fibrous
connective tissue and adipocytes, as seen in control non-
grafted animals at both follow-up times. Implant sites in which
MNP were injected diluted in saline showed a thin
subcutaneous layer consisting of MNP occupying a relatively
large area of subcutaneous tissue, although MNP were not seen
in other neighboring structures. Interestingly, after 1 month of
follow-up, the MNP were encapsulated by dense connective
tissue. In the implants of FF + RGD hydrogels, we found that
the injected materials were detectable at the implant site,
where they formed a homogeneous fibrillar structure restricted
to the injection site in the subcutaneous tissue after 1 week.
However, the hydrogel was completely reabsorbed and
undetectable in samples examined after 1 month. When FF
+ RGD + MNP hydrogels were implanted subcutaneously, we
found that MNP remained concentrated at the injection site
after 1 week of follow-up and did not disperse to neighbor
tissues. The findings after 1 month were very similar, although
Figure 7. (A) Subcutaneous deposit of magnetic (FF + RGD + MNP) hydrogel 1 month after injection. (B) Histological analysis (hematoxylin and
eosin staining) of the implant site in animals followed for 1 week and 1 month after in vivo grafting. Each animal in the 1-week and 1-month groups
was grafted with MNP diluted in saline (Serum + MNP), hydrogel consisting of FF + RGD (FF + RGD), hydrogel consisting of FF + RGD + MNP
(FF + RGD + MNP), or saline at different sites in the dorsal area, whereas controls were native non-grafted mice. For each condition, two images at
different magnifications are shown. Scale bar, 200 μm. Photographs are representative images of each experimental condition.
Figure 8. Injectability test. (A) Image of the magnetic hydrogel formed in an Eppendorf tube before and after disruption by vortex mixer. (B)
Magnetic hydrogel injected and driven through a labyrinth with a magnet. (C) Trypan blue analysis of five conditions: FF + RGD hydrogel (GEL),
FF + RGD hydrogel after syringe extrusion (GEL INJ), FF + RGD + MNP hydrogel (MNP GEL), FF + RGD + MNP after syringe extrusion
(MNP GEL INJ), and FF + RGD + MNP after syringe extrusion and application of a magnetic field (MNP GEL INJ + H). Three photographs are
shown for each condition. Cell membranes in live cells remained intact (white staining), while cell membranes were disrupted in dead cells (blue
staining). Three representative images for each experimental condition are shown.
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we found that host cells were able to encapsulate the material
implanted subcutaneously and migrate within the material.
Our preliminary morphometric analysis of control samples
and tissues grafted with the different biomaterials showed no
significant differences (P > 0.05) between groups in cell size,
nuclear size, or nuclear density (Table S2). If confirmed, these
results would be consistent with other evidence of the high
biocompatibility of these magnetic biomaterials. In previous
work, we showed that hydrogels containing MNP are highly
biocompatible and do not generate adverse effects when
grafted in vivo.38,52 Although our in vivo results strongly
suggest that the novel hydrogels described in the present study
are highly biocompatible, future irritation and corrosion tests
should be done to further investigate the biocompatibility of
these products in human skin.
Finally, we note that the results of the in vivo analyses also
provide valuable information on the stability of MNP in the
hydrogels and their biodistribution in animals. Stability is a key
parameter related to biocompatibility, and in this regard, our
results suggest that MNP remained stable within the hydrogel
and did not migrate to other tissues or structures. Specifically,
MNP were detected at the graft site, where they became
encapsulated, but not in peripheral tissues or in distal organs.
In addition, our analysis of major organs revealed no signs of
MNP migration, which is consistent with the results of the
blood analyses, thus suggesting that function was preserved in
these major organs. Together, these results are in agreement
with previous findings from our group that this type of MNP
was highly stable when combined with fibrin−agarose
biomaterials and showed no tendency to be released from
the hydrogel to the external environment under either ex vivo
or in vivo conditions.38,52 In particular, the present results
extend our previous work52 on the biodistribution of MNP in
Wistar rats followed for 12 weeks, in which we used a number
of techniques including magnetic resonance imaging, histology,
and magnetometry. These earlier results demonstrated that
MNP were mostly confined to the implantation area, with
some MNP biodistributed to lymphoid organs, albeit without
altering their histological structure or function.
Evaluation of Magnetic Hydrogels as Platforms for
the Delivery of Cells by Injection. Both magnetic and
nonmagnetic hydrogels retained their homogeneity after
injection, without appreciable signs of phase separation (Figure
8A). Assays with magnets showed, as expected, that non-
magnetic hydrogels could not be driven by the magnet. In
contrast, the noncontact magnetic force allowed controlled
displacement of the magnetic hydrogels through the labyrinth
without phase separationa property that is potentially useful
to achieve complete covering, filling of internal injuries, or
complete cargo release and spread in a particular internal area
(Figure 8B and Video S2). Previous work showed that shear-
thinning hydrogels may be usable as platforms for cell delivery
through a needle for potential in vivo applications.8,10−12 In
these cases, the shear-thinning characteristic of the hydrogel,
together with likely shear localization, protected most of the
cells from the shear forces, which made it possible to inject
them without substantial cell damage. In our experiments, we
corroborated that our magnetic hydrogels could also be used
for this purpose with minimal cell damage during injection,
along with the additional feature of magnetic actuation by
noncontact magnetic forces. As shown in Trypan blue assays
(Figure 8C), most cells remained alive after the hydrogel−cell
mixture was subjected to a magnetic field and subsequently to
syringe extrusion.
■ CONCLUSIONS
Novel short-peptide supramolecular magnetic hydrogels
showing improved physical properties were prepared and
studied. The inclusion of MNP in the hydrogel matrix
significantly increased the robustness and stability of the
hydrogels while at the same time improving injectability
properties through a shear-thinning/self-healing process. These
physical properties make the materials tested here ideal and
versatile candidates for numerous biomedical applications. We
tested these hybrid hydrogels as scaffolds for the 3D growth of
osteoblasts, and our results demonstrated that these hydrogels
promoted cell growth and did not degrade after 30 days of
culture. The injectability of these biomaterials was evaluated in
vivo by subcutaneous injections in mice. We showed that these
hydrogels remain located in the area of injection without
degradation 1 month after administration. During this time,
hydrogels did not produce toxicity and promoted cell growth
and cell migration through the hydrogel matrix. Additional
properties of these hydrogels are mobilization and stiffening in
response to noncontact magnetic forces. Many supramolecular
short-peptide hydrogels are formed at room temperature under
technically undemanding conditions and can therefore be used
to trap and deliver sensitive cargos such as cells with a
minimally invasive route of administration. We have shown
that the magnetic hydrogels analyzed in the present study are
also potential candidates for these applications. The further
development of hybrid magnetic hydrogels holds considerable
promise in biomedical research, particularly for in vivo
applications with a minimally invasive injection strategy.
■ EXPERIMENTAL SECTION
Materials. N-fluorenylmethoxycarbonyl diphenylalanine (Fmoc-
FF) and N-fluorenylmethoxycarbonyl arginylglycylaspartic acid
(Fmoc-RGD) peptides were purchased from Bachem Co. (Bubendorf
BL, Switzerland) and were used without further purification. Magnetic
nanoparticles (MNP) made of iron (purity of 99.7% or higher) and
with diameters in the range of 60−80 nm were purchased from
SkySpring Nanomaterials, Inc. (Houston, TX, USA). Polyethylene
glycol with a molecular mass of 400 g mol−1 (PEG-400),
glutaraldehyde (25% solution in water), mineral oil, and sorbitan
sesquioleate were all provided by Sigma-Aldrich (Burlington, MA,
USA). n-Hexane (minimum purity of 99%) was purchased from
Scharlab SL (Barcelona, Spain). Dulbecco’s modified Eagle’s Medium
(DMEM), penicillin (10,000 U/mL)/streptomycin (10,000 μg/mL)
solution, and UltraGlutamine 1200 mM (U-Gln) were all purchased
from Lonza (Basel, Switzerland). Alpha modification of minimum
essential medium (α modification with sodium bicarbonate,
ribonucleosides, and deoxyribonucleosides without L-glutamine) was
purchased from Sigma-Aldrich. HyClone characterized fetal bovine
serum (FBS) was purchased from Cytiva (Marlborough, MA, USA).
Functionalization of MNP. To obtain adequate integration of
MNP in the peptide hydrogels, suitable functionalization was
required, for which we followed a previously published protocol.33
Briefly, we first coated the MNP with PEG using the microemulsion
method of Chatterjee et al.54 Then, we suspended 100 mg PEG-
coated MNP in 1.5 mL of an aqueous basic (pH approx. 10.5)
solution of Fmoc-FF (0.5% w/v). The resulting suspension was
sonicated for 10 min and then centrifuged for 5 min at 10,000 rpm
(Sigma 1-14 centrifuge) to obtain MNP with a double coating of PEG
and Fmoc-FF. We removed the supernatant and used the double-
coated MNP to prepare the magnetic hydrogels. A complete
characterization of the physicochemical properties of these particles
was reported previously.33 In particular, the MNP demonstrated
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typical soft ferromagnetic behavior with a high saturation magnet-
ization of 1521 ± 15 kA/m, a low remnant magnetization of 62.3 ±
2.4 kA/m, and negligible effects of PEG coating on the magnetic
properties.33
Preparation of Hydrogels. To prepare nonmagnetic hydrogels,
we proceeded as follows. First, we placed an appropriate amount of
Fmoc-FF peptide in a vial, to which we added deionized water to a
final concentration of 20 mM. We then immersed the resulting
suspension in an ultrasonic bath (HSt Powersonic 603) to achieve
homogeneous dispersion of the peptides (approximately 1 h). Then,
we added small amounts of a 0.5 M NaOH solution by pipette until a
clear solution was obtained at a pH of approximately 10.5. We
measured the pH value with a HACH sensION+ pH 3 pH meter that
was previously calibrated with pH 4, 7, and 10 buffer solutions. Then,
we added appropriate amounts of Fmoc-RGD powders to deionized
water in a pressure vial to obtain a peptide concentration of 20 mM.
This solution became transparent immediately with a pH of approx.
3.98. To prepare hybrid Fmoc-FF/Fmoc-RGD solutions, we mixed
them at a ratio of 7:3, whereas for pure Fmoc-FF hydrogels (without
Fmoc-RGD peptide), we mixed the Fmoc-FF peptide solution with
water at a ratio of 7:3. Finally, we induced gelation in the hybrid
Fmoc-FF/Fmoc-RGD or pure Fmoc-FF peptide solutions by adding
equal volumes of a 50:50 mixture of DMEM and water. The final pH
of the Fmoc-FF hydrogel was approximately 7.4, and the final pH of
the Fmoc-FF/Fmoc-RGD hydrogel was approximately 7.1.
To prepare magnetic hydrogels, we slightly modified the previous
protocol by adding appropriate amounts of MNP with double-coating
(PEG + Fmoc-FF) to the peptide solutions before the addition of
DMEM. The final concentration of MNP was 0.1 vol %. In some
cases, we induced the formation of anisotropic, elongated structures of
MNP in the hydrogel microstructure by applying a vertical magnetic
field (H = 15 kA m−1) during the first hour of gelation after the
addition of DMEM. A solenoid connected to a DC power supply was
used to apply the magnetic field.
All hydrogels were prepared according to the procedure detailed
above. In all cases, hydrogel properties were characterized 24 h after
DMEM was added to allow for complete gelation. A summary of the
different hydrogels studied in this work is shown in Table 1.
Physicochemical Characterization of Hydrogels. Fourier-
Transform Infrared Spectroscopy. We recorded FTIR spectra with a
PerkinElmer Two FTIR ATR spectrometer. The nonmagnetic and
magnetic hydrogels were compressed onto the diamond crystal, and
the spectra were scanned over a range of 4000 to 450 cm−1.
Transmission Electron Microscopy (TEM). The hydrogels were
examined with a LIBRA 120 PLUS Carl Zeiss apparatus. Hydrogels
were vortexed and diluted with water 1:10. Hydrogel samples were
placed on a 300-mesh copper grid stained with 1% aqueous uranyl
acetate solution and dried at room temperature for 30 min. At least six
different areas of hydrogel for each experimental condition were
analyzed.
Circular Dichroism. The CD spectra were recorded with a Jasco J-
815 spectropolarimeter and 150 W xenon lamp. The hydrogels were
jellified into a 0.1 mm quartz cell (Hellma 0.1 mm quartz Suprasil)
according to the protocol described above. Spectra were obtained
from 200 to 320 nm with a 1-nm step and 0.5 s integration time per
step at 20 °C.
Mechanical Evaluation of Hydrogels. Gelation Kinetics. We
investigated the gelation kinetics of hydrogels by obtaining rheological
measurements with a Haake MARS III controlled-stress rheometer
(Thermo Fisher Scientific, Waltham, MA, USA) equipped with a
double cone−plate sensor 60 mm in diameter at a 2° apex angle
(sensor DC60/2° Ti L). For these assays, we followed the protocol
for the preparation of magnetic and nonmagnetic hydrogels described
above and poured the mixture in the measuring system of the
rheometer before adding the water/DMEM mixture. We then added
the water/DMEM mixture directly to the peptide mixture in the
measuring system of the rheometer to induce gelation and
immediately afterward subjected the gelling sample to an oscillatory
shear strain of fixed frequency (1 Hz) and amplitude (γ0 = 0.001)
while monitoring the resulting viscoelastic moduli as a function of
time. For FF + RGD + MNP + H samples, we applied a 15 kA/m
magnetic field during gelation by using a coil connected to a power
supply placed coaxially to the rheometer axis. The strain amplitude (γ0
= 0.001) used in these assays was low enough to ensure that
formation of the gel microstructure was unperturbed. Characterization
was carried out at a constant temperature of 37.0 ± 0.1 °C. We
obtained measurements for at least three fresh samples for each
experimental condition.
Characterization of the Mechanical Properties of Hydrogels. We
characterized the mechanical properties of the hydrogels under
oscillatory shear strains by using the same rheometer as in the
previous section, equipped with a double-plate sensor of 35 mm in
diameter and rough surfaces to avoid wall slip (sensor P35 Ti L S
serrated, Thermo Fisher Scientific). Characterization was carried out
at a constant temperature of 37.0 ± 0.1 °C. First, we subjected the
hydrogels to amplitude sweeps, for which the frequency of oscillation
was kept at 1 Hz and the amplitude of the oscillatory strain, γ0, was
increased stepwise from 0.0001 to 2 along a logarithmic ramp. These
measurements provided the values of storage (G′) and loss (G″)
moduli as a function of γ0. Then, we performed frequency sweep tests,
for which the amplitude of the shear strain was fixed at γ0 = 0.001 and
the frequency of oscillation was increased stepwise from 0.1 to 16 Hz.
These measurements provided the values of G′ and G″ of the
hydrogels as a function of frequency (i.e., the mechanical spectra).
A fresh sample was used for each amplitude and frequency sweep
and each experimental condition, and we obtained measurements for
at least three different samples for each experimental condition. In this
article, we report the corresponding mean values and standard errors
of the measurements.
Self-Healing Behavior of Hydrogels. We investigated the self-
healing behavior of the hydrogels of the present work by obtaining
rheological measurements with the same rheometer equipped with a
double cone-plate sensor (sensor DC60/2° Ti L) as described above.
The hydrogel was produced in a vial according to the gel preparation
protocol noted above and was maintained for 24 h. Then, it was
disrupted with a vortex mixer, drawn into a syringe with a 20G gauge
needle, and injected into the measuring system of the rheometer. The
combination of vortex mixing and the stress produced during
injection led to the complete disruption of the sample. The sample
was then immediately subjected to an oscillatory shear strain of fixed
frequency (1 Hz) and amplitude (γ0 = 0.001) while monitoring the
resulting viscoelastic moduli as a function of time. For FF + RGD +
MNP + H samples, we applied a 15 kA/m magnetic field during
gelation with a coil connected to a power supply placed coaxially to
the axis of the rheometer. We obtained measurements for at least
three fresh samples for each experimental condition.
Ex Vivo Biocompatibility of Hydrogels. The gel preparation
protocol reported above was slightly modified to incorporate cells in
Table 1. Summary of the Main Preparation Characteristics








FF Fmoc-FF no no
FF + MNP Fmoc-FF yes no
FF + MNP + H Fmoc-FF yes yes
FF + RGD Fmoc-FF + Fmoc-
RGDd
no no










aPeptide concentration was 20 mM in all cases. bConcentration of
MNP was 0.1 vol %. MNP were previously double-coated with PEG +
Fmoc-FF. cStrength of the magnetic field was H = 15 kA m−1 and was
maintained during the first hour of gelation. dThe Fmoc-FF-to-Fmoc-
RGD ratio was 7:3.
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the hydrogels. First, we sterilized all reagents and carried out gel
preparation under sterile conditions. Then, we followed the previous
steps for gel preparation, except for the last step: Instead of DMEM,
we added normal human osteoblasts (hOB #35, passage 8) dispersed
in complete αMEM (composition as below). We chose a density of 1
million cells per culture well (human primary osteoblasts, Lonza,
Basel, Switzerland). We added αMEM supplemented with Hyclone
FBS 10%, U-Gln (2 mM), and penicillin/streptomycin (100 U/mL
and 100 μg/mL, respectively) and cultured the samples under
standard culture conditions for two different culture periods of 12 and
38 days. At the end of each period, we examined the samples after
hematoxylin and eosin (HE) staining (samples were fixed for 72 h in
formaldehyde at room temperature and then paraffin-embedded;
sections 4 μm thick were made, deparaffinized in xylene, hydrated,
and stained with HE). Cell proliferation for selected samples was
investigated after immunostaining with an anti-human Ki-67 antigen
antibody (monoclonal mouse anti-human Ki-67 antigen, clone MIB-1,
from Agilent, Santa Clara, CA, USA).
In separate experiments, we cultured human fibroblasts (20,000
cells in 1 mL of hydrogel per culture well) in FF + RGD samples for
24 h, 72 h, and 1 week under standard culture conditions and used a
NanoDrop 2000 UV−Vis spectrophotometer (Thermo Fisher
Scientific) to quantify the DNA released according to previously
established protocols.38 We tested at least three different hydrogel
samples per experimental condition.
Degradation and Swelling Behavior. For degradation studies,
we deposited the hydrogels (three samples per experimental
condition) in well plates, which were then immersed in DMEM
and kept at 37 °C in a laboratory incubator. Every 24 h, the DMEM
medium was changed, and we monitored the physical integrity of the
hydrogels by direct observation and photography without artificial
magnification for a total period of 12 days.
To study swelling behavior, we prepared the hydrogels (four
samples of 500 μL per each experimental condition), placed them in
Eppendorf tubes, added 500 μL of water, and stored the tubes at
room temperature. Every 24 h, we removed the supernatant and
calculated the mass of the hydrogels by subtracting the mass of the
empty tube from the mass of the tube + swelled hydrogel. Mass
measurements were obtained with a microbalance. Then, we added
500 μL of water and stored the hydrogels at room temperature until
the next measurement.
In Vivo Biocompatibility of Particles and Hydrogels. Biocompat-
ibility of the MNP and hydrogels was assessed in 12 BALB/c
laboratory mice. The animals were deeply anesthetized with ketamine
and acepromazine, and a subcutaneous injection was made in each
mouse (see Video S1) consisting of 300 μL of (i) MNP diluted in
saline (0.1% v/v PEG-Fmoc-FF-coated MNP), (ii) hydrogel
consisting of FF + RGD (FF/RGD at a ratio of 7:3), (iii) hydrogel
consisting of FF + RGD + MNP (0.1% v/v PEG-Fmoc-FF-coated
MNP in a hydrogel with FF/RGD at a ratio of 7:3), or (iv) saline only
(used as a control). Each animal received one injection of each of the
four materials in different parts of the dorsal area, with a separation of
1 cm between implant sites. Six animals were killed by intraperitoneal
injection of a euthanasia solution (Eutanax 200, Fatro Ibeŕica,
Barcelona, Spain) after 7 or 30 days of follow-up, and the main organs
(spleen, liver, kidney, heart, and lung), along with the four injection
areas, were removed and analyzed histologically. As a control, we used
one BALB/c mouse with no implants for each of the two follow-up
periods.
Evaluation of Magnetic Hydrogels as Platforms for the Delivery
of Cells by Injection. First, we investigated the injectability of the
hydrogels and their potential actuation by magnetic forces. We
prepared the hydrogel in an Eppendorf tube, and after complete
gelation, we disrupted the hydrogel with a vortex mixer. Immediately
thereafter, we drew the hydrogel into a syringe with a 0.3 mm gauge
and injected it into a petri dish to which we had previously glued a
homemade labyrinth. Then, with the help of a permanent magnet, we
tried to move the injected hydrogel through the labyrinth. In a
separate experiment, we proceeded as described, but before the
disrupted hydrogel was drawn into the syringe, we mixed it with
human fibroblasts (200,000 cells per mL of hydrogel). In some
experimental groups, we subjected the cell/hydrogel mixture to a
magnetic field in a petri dish as described above. In other groups, we
injected the cell/hydrogel mixture into culture wells, and after 10 min,
we analyzed cell viability by Trypan blue staining to observe whether
the hydrogel protected cells from mechanical damage caused by
shearing forces and field-induced displacement of the magnetic
particles. As a control, we analyzed cell/hydrogel samples that were
not subjected to syringe use or to a magnetic field. These experiments
were done for three different hydrogels in each experimental
condition. For cell viability studies, we used at least three samples
for each experimental condition.
Statistical Analyses. For blood analyses, morphological analysis of
histological results, and other statistical comparisons, the data
obtained for each study group were compared with the Mann−
Whitney statistical test in RealStatistics software (Dr. Charles Zaiontz,
Purdue University, West Lafayette, IN, USA). In all cases, P values
below 0.05 were considered statistically significant.
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